Namyang Dairy Imperial XO, Ranked No.1 for Two Consecutive Years in the Infant Formula Category of the 'Korea Industry Purchase Confidence Index'

[Asia Economy Reporter Eunmo Koo] Namyang Dairy Products announced on the 18th that its infant formula brand ‘Imperial XO’ has achieved first place in the infant formula category for two consecutive years in the ‘2022 Korea Industry Purchase Assurance Index (KPEI)’ survey hosted by the Korea Marketing Association and conducted by Consumer Evaluation.

The Korea Marketing Association and Consumer Evaluation annually publish the Korea Industry Purchase Assurance Index (KPEI) to lead the establishment and development of a culture where customers can confidently purchase products and services. This year, brand evaluations by category were conducted through an online survey of approximately 3,200 male and female consumers nationwide.

Imperial XO, which won first place in the infant formula category, is a product manufactured through a state-of-the-art assurance process that manages raw materials according to domestic standards as well as international safety standards such as those of the European Union (EU), and is filtered through 133 installed seven-layer HEPA filters that even purify the air.

Additionally, based on 58 years of breast milk research, it is formulated with zinc (self-defense), taurine (growth), and gamma-linolenic acid (brain) at average breast milk content levels, which are essential for infant growth and development. For golden stools, it is the first infant formula in Korea to apply microbiome technology.